Correlation Between Neurocrine Biosciences and 17136MAB8

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and 17136MAB8 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and 17136MAB8 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and CHD 5 15 JUN 52, you can compare the effects of market volatilities on Neurocrine Biosciences and 17136MAB8 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of 17136MAB8. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and 17136MAB8.

Diversification Opportunities for Neurocrine Biosciences and 17136MAB8

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Neurocrine and 17136MAB8 is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and CHD 5 15 JUN 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 17136MAB8 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with 17136MAB8. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 17136MAB8 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and 17136MAB8 go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and 17136MAB8

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.97 times more return on investment than 17136MAB8. However, Neurocrine Biosciences is 1.03 times less risky than 17136MAB8. It trades about 0.02 of its potential returns per unit of risk. CHD 5 15 JUN 52 is currently generating about 0.01 per unit of risk. If you would invest  12,008  in Neurocrine Biosciences on September 24, 2024 and sell it today you would earn a total of  1,534  from holding Neurocrine Biosciences or generate 12.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy57.03%
ValuesDaily Returns

Neurocrine Biosciences  vs.  CHD 5 15 JUN 52

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
17136MAB8 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days CHD 5 15 JUN 52 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 17136MAB8 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Neurocrine Biosciences and 17136MAB8 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and 17136MAB8

The main advantage of trading using opposite Neurocrine Biosciences and 17136MAB8 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, 17136MAB8 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 17136MAB8 will offset losses from the drop in 17136MAB8's long position.
The idea behind Neurocrine Biosciences and CHD 5 15 JUN 52 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA